J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 7,449 shares at $16.18 ($121K) on 2019-04-17, disclosed to the SEC on 2019-04-19.
Open-market sale of $121k FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |